Clinical Trials List
2010-02-01 - 2012-12-31
Phase III
Terminated10
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 謝元凱 Division of Cardiovascular Diseases
- 楊正旭 Division of Cardiovascular Diseases
- 薛書凱 Division of Cardiovascular Diseases
- Shyh-Ming Chen Division of Cardiovascular Diseases
- 方志元 Division of Cardiovascular Diseases
- 洪志凌 Division of Cardiovascular Diseases
- 葉漢根 Division of Cardiovascular Diseases
- 陳建仁 Division of Cardiovascular Diseases
- 陳永隆 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 邱富群 Division of Cardiovascular Diseases
- Hsien Li Kao Division of Cardiovascular Diseases
- 陳建鈞 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
200 participants
-
Global
10930 participants
